Cargando…

Src Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment

The underlying mechanisms leading to antiestrogen resistance in estrogen-receptor α (ER)-positive breast cancer is still poorly understood. The aim of this study was therefore to identify biomarkers and novel treatments for antiestrogen resistant breast cancer. We performed a kinase inhibitor screen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larsen, Sarah L., Laenkholm, Anne-Vibeke, Duun-Henriksen, Anne Katrine, Bak, Martin, Lykkesfeldt, Anne E., Kirkegaard, Tove
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338193/ https://www.ncbi.nlm.nih.gov/pubmed/25706943 http://dx.doi.org/10.1371/journal.pone.0118346

Ejemplares similares

Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
por: Larsen, Sarah L, et al.
Publicado: (2015)

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
por: Løkkegaard, Sanne, et al.
Publicado: (2021)

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors
por: Frogne, Thomas, et al.
Publicado: (2009)

Activation of the Her2/neu receptor leads to antiestrogen resistance, but acquired resistance is not caused by altered ErbB expression and activation
por: Larsen, SS, et al.
Publicado: (2000)

FLTX2: A Novel Tamoxifen Derivative Endowed with Antiestrogenic, Fluorescent, and Photosensitizer Properties
por: Díaz, Mario, et al.
Publicado: (2021)

Resveratrol Sensitizes Tamoxifen in Antiestrogen-Resistant Breast Cancer Cells with Epithelial-Mesenchymal Transition Features
por: Shi, Xiao-Peng, et al.
Publicado: (2013)

Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling
por: Larsen, Martin J., et al.
Publicado: (2013)

Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7.
por: Lykkesfeldt, A. E., et al.
Publicado: (1984)

Cytokeratin on Frozen Sections of Sentinel Node May Spare Breast Cancer Patients Secondary Axillary Surgery
por: Stovgaard, Elisabeth Specht, et al.
Publicado: (2012)

HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells
por: Alam, Muhammad Wasi, et al.
Publicado: (2016)

Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study
por: Lyng, Maria B., et al.
Publicado: (2012)

The Antiestrogens Tamoxifen and Fulvestrant Abolish Estrogenic Impacts of 17α-ethinylestradiol on Male Calling Behavior of Xenopus laevis
por: Hoffmann, Frauke, et al.
Publicado: (2012)

Inhibition of Antiestrogen-Promoted Pro-Survival Autophagy and Tamoxifen Resistance in Breast Cancer through Vitamin D Receptor
por: Li, Ye, et al.
Publicado: (2021)

The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistance
por: Suba, Zsuzsanna
Publicado: (2015)

Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study
por: Lyng, Maria B., et al.
Publicado: (2013)

Ninth grade school performance in Danish childhood cancer survivors
por: Andersen, Klaus Kaae, et al.
Publicado: (2017)

Risk of cardiovascular events in men treated for prostate cancer compared with prostate cancer-free men
por: Moustsen, Ida Rask, et al.
Publicado: (2019)

OR11-02 Structural Determinants of Pure Antiestrogenic Activity
por: Vallet, Amandine, et al.
Publicado: (2023)

Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9
por: Jiang, Min, et al.
Publicado: (2013)

Antiestrogen- and tamoxifen-induced effects on calcium-activated chloride currents in epithelial cells carrying the ∆F508-CFTR point mutation
por: Imberti, Roberto, et al.
Publicado: (2018)

Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data
por: Krøigård, Anne Bruun, et al.
Publicado: (2016)

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
por: Elias, D., et al.
Publicado: (2019)

Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis
por: Krøigård, Anne Bruun, et al.
Publicado: (2015)

Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression
por: Krøigård, Anne Bruun, et al.
Publicado: (2018)

Protein Aggregation Patterns Inform about Breast Cancer Response to Antiestrogens and Reveal the RNA Ligase RTCB as Mediator of Acquired Tamoxifen Resistance
por: Direito, Inês, et al.
Publicado: (2021)

Estrogenic or antiestrogenic therapies for multiple myeloma?
por: Sola, Brigitte, et al.
Publicado: (2007)

RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families
por: Larsen, Martin J, et al.
Publicado: (2014)

Genomic Analyses of Breast Cancer Progression Reveal Distinct Routes of Metastasis Emergence
por: Krøigård, Anne Bruun, et al.
Publicado: (2017)

Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells
por: Woo, Yu Mi, et al.
Publicado: (2015)

Intratumor Genetic Heterogeneity of Breast Carcinomas as Determined by Fine Needle Aspiration and TaqMan Low Density Array
por: Lyng, Maria B., et al.
Publicado: (2007)

Syringomatous Tumour Presenting as Inversion of a Supernumerary Nipple
por: Öwall, Louise, et al.
Publicado: (2019)

Capsulectomy Can Successfully Treat Chronic Encapsulated Breast Seroma: A Case Report
por: Fosheim, Kjersti, et al.
Publicado: (2022)

Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines
por: Journe, Fabrice, et al.
Publicado: (2006)

Discovery of Highly Functionalized 5-hydroxy-2H-pyrrol-2-ones That Exhibit Antiestrogenic Effects in Breast and Endometrial Cancer Cells and Potentiate the Antitumoral Effect of Tamoxifen
por: Guerra-Rodríguez, Miguel, et al.
Publicado: (2022)

FRI441 Antiestrogens To Treat Hypogonadotropic Hypogonadism In Male Users Of Anabolic-androgenic Steroids - A Clinical Pilot Study
por: Bordado Henriksen, Hans Christian, et al.
Publicado: (2023)

Treatment intensity and survival in patients with relapsed or refractory diffuse large B-cell lymphoma in Denmark: a real-life population-based study
por: Arboe, Bente, et al.
Publicado: (2019)

Return to work for patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation
por: Arboe, Bente, et al.
Publicado: (2017)

Tamoxifen and Src kinase inhibitors as neuroprotective/neuroregenerative drugs after spinal cord injury
por: Salgado, Iris K., et al.
Publicado: (2015)

SRC Promotes Tamoxifen Resistance in Breast Cancer via Up-Regulating SIRT1
por: Zhou, Jun, et al.
Publicado: (2020)

Identification of genes for normalization of real-time RT-PCR data in breast carcinomas
por: Lyng, Maria B, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_rji3ersmfr547ec2jmk7dtpj3m